These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31324183)

  • 1. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease.
    Palanca A; Castelblanco E; Betriu À; Perpiñán H; Soldevila B; Valdivielso JM; Bermúdez-Lopez M; Puig-Jové C; Puig-Domingo M; Groop PH; Fernández E; Alonso N; Mauricio D
    Cardiovasc Diabetol; 2019 Jul; 18(1):93. PubMed ID: 31324183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes.
    Palanca A; Castelblanco E; Perpiñán H; Betriu À; Soldevila B; Valdivielso JM; Bermúdez M; Duran X; Fernández E; Puig-Domingo M; Groop PH; Alonso N; Mauricio D
    Atherosclerosis; 2018 Sep; 276():50-57. PubMed ID: 30032025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound.
    Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E;
    PLoS One; 2017; 12(10):e0186665. PubMed ID: 29045466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
    Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.
    Betriu A; Martinez-Alonso M; Arcidiacono MV; Cannata-Andia J; Pascual J; Valdivielso JM; Fernández E;
    Nephrol Dial Transplant; 2014 Jul; 29(7):1415-22. PubMed ID: 24586070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.
    Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E;
    BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
    Valdivielso JM; Rodríguez-Puyol D; Pascual J; Barrios C; Bermúdez-López M; Sánchez-Niño MD; Pérez-Fernández M; Ortiz A
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1938-1966. PubMed ID: 31412740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients.
    Kim JK; Song YR; Kim MG; Kim HJ; Kim SG
    BMC Cardiovasc Disord; 2013 Nov; 13():96. PubMed ID: 24192205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.
    Fernández-Friera L; Peñalvo JL; Fernández-Ortiz A; Ibañez B; López-Melgar B; Laclaustra M; Oliva B; Mocoroa A; Mendiguren J; Martínez de Vega V; García L; Molina J; Sánchez-González J; Guzmán G; Alonso-Farto JC; Guallar E; Civeira F; Sillesen H; Pocock S; Ordovás JM; Sanz G; Jiménez-Borreguero LJ; Fuster V
    Circulation; 2015 Jun; 131(24):2104-13. PubMed ID: 25882487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Shroff GR; Sanchez OA; Miedema MD; Kramer H; Ix JH; Duprez DA; Jacobs DR
    Atherosclerosis; 2020 Oct; 310():75-82. PubMed ID: 32919188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference.
    Martín M; Valls J; Betriu A; Fernández E; Valdivielso JM
    Atherosclerosis; 2015 Jul; 241(1):264-70. PubMed ID: 25748053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study.
    Ruscitti P; Cipriani P; Masedu F; Romano S; Berardicurti O; Liakouli V; Carubbi F; Di Benedetto P; Alvaro S; Penco M; Valenti M; Giacomelli R
    PLoS One; 2017; 12(1):e0170108. PubMed ID: 28103312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
    Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E;
    Nephrol Dial Transplant; 2017 Mar; 32(3):513-520. PubMed ID: 27190385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease.
    Forné C; Cambray S; Bermudez-Lopez M; Fernandez E; Bozic M; Valdivielso JM;
    Clin Kidney J; 2020 Aug; 13(4):631-639. PubMed ID: 32905292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Salles GC; Leite NC; Salles GF
    Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study.
    Junyent M; Martínez M; Borràs M; Coll B; Valdivielso JM; Vidal T; Sarró F; Roig J; Craver L; Fernández E
    BMC Nephrol; 2010 Jul; 11():14. PubMed ID: 20609210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease.
    Sobchak C; Akhtari S; Harvey P; Gladman D; Chandran V; Cook R; Eder L
    Arthritis Rheumatol; 2019 Oct; 71(10):1651-1659. PubMed ID: 31165591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.